Skip to search.
 FTSE 100 Down 0.48%

Becton, Dickinson and Company (BDX)

-NYSE
174.76 Down 0.15(0.09%) 17:09 - Nasdaq Real Time Price
Prev Close:174.91
Open:174.84
Bid:174.47 x 100
Ask:174.55 x 200
1y Target Est:183.18
Beta:1.01975
Earnings Date:2 Nov - 7 Nov (Est.)
Day's Range:174.03 - 175.26
52wk Range:128.87 - 177.78
Volume:135,551
Avg Vol (3m):840,141
Market Cap:37.21b
P/E (ttm):33.35
EPS (ttm):5.24
Div & Yield:2.64 (1.52%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for BDX at this time.

Comparison

Symbol% ChgMkt Cap
BDXDown 0.09%37.21b
BAXDown 0.44%25.98b
ABTUp 0.35%64.76b

Key Statistics

Forward P/E (1 yr):18.45
P/S (ttm):3.02
Ex-Dividend Date:07-Sep-16

Analysts

Annual EPS Est (Sep-16) :8.57
Quarterly EPS Est (Sep-16) :2.10
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.52

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company’s BD Medical segment offers syringes and pen needles for diabetes; needles, syringes, and intravenous cat... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback